Browse by ["viewname_eprint_publisher" not defined]

A

Alchalby, H. and Badbaran, A. and Kobbe, G. and Hahn, J. and Wolff, D. and Bornhaeuser, M. and Baurmann, H. and Bock, O. and Bethge, W. and Bacher, U. and Fehse, B. and Zander, A. R. and Kroeger, N. (2010) Utility of JAK2V617F and MPLW515L/K mutation analysis in the setting of allogeniec stem cell transplantation for myelofibrosis. ONKOLOGIE, 33 (Suppl6). p. 26. ISSN 0378-584X

B

Balsiger, C. and Mumm, F. and Holler, E. and Herzberg, P. Y. and Hilgendorf, I and Hemmati, P. and von Harsdorf, S. and Greinix, H. and Mitchell, S. A. and Wolff, D. and Heussner, P. (2015) Correlation between somatic comorbidities and anxiety and depression in patients after allogeneic hematopoietic stem cell transplantation. KARGER, BASEL.

Bergmann, Lothar and Brugger, Wolfram and Herr, Wolfgang and Mackensen, Andreas and Multhoff, Gabriele (2015) What Opportunities are offered by Immuno Oncology for a indications cross over Long Time Survival? ONCOLOGY RESEARCH AND TREATMENT, 38. pp. 6-11. ISSN 2296-5270, 2296-5262

Bernardi, C. and Wolff, D. and Heudobler, D. and Lueke, F. and Hies, J. and Seitz, F. and Pukrop, T. and Herr, W. and Herrmann, A. (2023) Uninformed consent in clinical trials with cancer patients: development and pilot testing of evidence-based, patient-centred communication strategies. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Bethge, W. A. and Beelen, D. and Bornhaeuser, M. and Stelljes, M. and Zabelina, T. and Finke, J. and Kobbe, G. and Wolff, D. and Wagner, E. -M. and Christopeit, M. and Schmid, C. and Ottinger, H. and Gorth, C. and Faul, C. and Bertz, H. and Rachlis, E. and Wolschke, C. and Schetelig, J. and Horn, P. and Mueller, C. and Mytilineos, J. and Fleischhauer, K. and Kroeger, N. and Ayuk, F. (2017) Impact of donor-recipient HLA-disparity on outcome of allogeneic stem cell transplantation for AML and MDS: a retrospective German-stem-cell-transplant-registry (DRST) study of the German working group for blood and marrow transplantation (DAG-KBT e.V.). KARGER, BASEL.

Bittrich, M. and Kriegsmann, K. and Tietze-Stolley, C. and Movassaghi, K. and Grube, M. and Vucinic, V. and Wehler, D. and Burchert, A. and Schmidt-Hieber, M. and Rank, A. and Duerk, H. A. and Metzner, B. and Kimmich, C. and Kunz, C. and Hartmann, F. and Khandanpour, C. and de Wit, M. and Holtick, U. and Kiehl, M. and Kiani, A. and Naumann, R. and Scholz, C. W. and Tischler, H.-J. and Goerner, M. and Brand, F. and Kroeger, N. (2023) German study on mobilization and collection of CD34+progenitor cells in patients with multiple myeloma regarding new induction therapies and the impact of the SARS-CoV-2 pandemic. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Bittrich, M. and Movassaghi, K. and Vucinic, V. and Grube, M. and Kriegsmann, K. and Duerk, H. A. and Kunz, C. and Wehler, D. and Metzner, B. and Hentrich, M. and de Wit, M. and Schmidt-Hieber, M. and Humpe, A. and Kroeger, N. (2020) NIS OPTIMOB: First results of real-world data on mobilization and collection of hematopoietic stem and progenitor cells in patients with multiple myeloma and lymphoma in Germany. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Bittrich, Max and Kriegsmann, Katharina and Tietze-Stolley, Carola and Movassaghi, Kamram and Grube, Matthias and Vucinic, Vladan and Wehler, Daniela and Burchert, Andreas and Schmidt-Hieber, Martin and Rank, Andreas and Duerk, Heinz A. and Metzner, Bernd and Kimmich, Christoph and Hentrich, Marcus and Kunz, Christian and Hartmann, Frank and Khandanpour, Cyrus and de Wit, Maike and Holtick, Udo and Kiehl, Michael and Stoltefuss, Andrea and Kiani, Alexander and Naumann, Ralph and Scholz, Christian W. and Tischler, Hans-Joachim and Goerner, Martin and Brand, Franziska and Ehmer, Martin and Kroeger, Nicolaus (2023) A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation. KARGER, BASEL.

Black, A. and Ditz, D. and Holler, E. and Schmitz, G. and Ahrens, N. (2011) Are antibodies to the blood group antigen M clinically relevant? ONKOLOGIE, 34 (Suppl6). p. 57. ISSN 0378-584X

Blecha, Christiane and Angstwurm, Klemens and Wolff, Daniel and Holler, Ernst and Helbig, Horst and Grassinger, Jochen and Rennert, Janine and Kleiter, Ingo and Huber, Elisabeth and Schmid, Christoph and Dietrich-Ntoukas, Tina (2015) Retinal Involvement in a Patient with Cerebral Manifestation of Chronic Graft-Versus-Host-Disease. ONCOLOGY RESEARCH AND TREATMENT, 38 (10). pp. 532-534. ISSN 2296-5270, 2296-5262

Bleckmann, A. and Conradi, L. -C. and Wachter, A. and Bayerlova, M. and Wolff, A. and Schildhaus, H. -U. and Stanek, K. and Stadelmann, C. and Proescholdt, M. and Homayounfar, K. and Pukrop, T. and Beissbarth, T. (2017) Molecular consensus subtyping of colorectal carcinoma in liver and brain metastases. KARGER, BASEL.

Bleckmann, A. and Kirchner, B. and Nietert, M. and Beissbarth, T. and Balkenhol, M. and Egert, D. and Siam, L. and Rhode, V. and Pukrop, T. (2017) Impact of pre-OP frailty on short-and long-term mortality after resection of limited brain metastases: risk assessment by various indices of activities of daily living. KARGER, BASEL.

Boch, T. and Reinwald, M. and Postina, P. and Cornely, O. A. and Heussel, C. P. and Heinz, W. and Hoenigl, M. and Eigl, S. and Lehrnbecher, T. and Hahn, J. and Claus, B. and Lauten, M. and Egerer, G. and Mueller, M. C. and Will, S. and Merker, N. and Hofmann, W. K. and Buchheidt, D. and Spiess, B. (2015) Identification of invasive fungal infections in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA microarray. KARGER, BASEL.

Boch, T. and Spiess, B. and Cornely, O. A. and Vehreschild, J. J. and Rath, P. M. and Steinmann, J. and Heinz, W. and Hahn, J. and Krause, S. W. and Kiehl, M. G. and Egerer, G. and Koldehoff, M. and Liebregts, T. and Klein, M. and Nolte, F. and Will, S. and Merker, N. and Hofmann, W. K. and Buchheidt, D. and Reinwald, M. (2015) Performance of combinations of Aspergillus PCR, multifungal DNA microarray, galactomannan, 1,3-beta-D-glucan and Aspergillus azole resistance PCRs in blood and BAL samples for diagnosis and characterization of invasive fungal infections in haematological patients. KARGER, BASEL.

Boell, B. and Pluetschow, A. and Eichenauer, D. A. and Thielen, I and von Tresckow, B. and Atta, J. and Pfreundschuh, M. and Feuring-Buske, M. and Vogelhuber, M. and Soekler, M. and Fuchs, M. and Engert, A. and Borchmann, P. (2014) German Hodgkin Study Group Phase I trial of Doxorubicin, Vinblastine, Dacarbazine, and Lenalidomide (AVD-Rev) for elderly Hodgkin Lymphoma patients. KARGER, BASEL.

Boettcher, M. and Renner, K. and Berger, R. and Mentz, K. and Thomas, S. and Cardenas-Conejo, Z. E. and Dettmer, K. and Oefner, P. J. and Mackensen, A. and Kreutz, M. and Mougiakakos, D. (2018) Immunometabolic impact of D-2HG on human T-cells. KARGER, BASEL.

Boettcher, M. and Renner, K. and Mentz, K. and Kreutz, M. and Mackensen, A. and Mougiakakos, D. (2017) Oncometabolite D-2HG impacts both metabolism and function of T cells. KARGER, BASEL.

Boettcher, M. and Renner, K. and Mentz, K. and Mackensen, A. and Kreutz, M. and Mougiakakos, D. (2016) Oncometabolite 2-hydroxyglutarate impacts metabolism but not function of T cells. KARGER, BASEL.

Borchmann, P. and Kobe, C. and Pluetschow, A. and Greil, R. and Meissner, J. and Topp, M. S. and Ostermann, H. and Dierlamm, J. and Mohm, J. and Thiemer, J. and Soekler, M. and Kerkhoff, A. and Ahlborn, M. and Halbsguth, T. and Martin, S. and Keller, U. and Balabanov, S. and Pabst, T. and Vogelhuber, M. and Huettmann, A. and Wilhem, M. and Zijlstra, J. M. and Moccia, A. and Broeckelmann, P. J. and von Tresckow, B. and Fuchs, M. and Eich, H. and Baues, C. and Hallek, M. and Diehl, V and Dietlein, M. and Engert, A. (2020) Positron emission tomography guided omission of radiotherapy in early-stage unfavorable Hodgkin Lymphoma: Final results of the international, randomized Phase III HD17 trial by the German Hodgkin Study Group. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Bouazzaoui, A. and Spacenko, E. and Mueller, G. and Huber, E. and Schubert, T. and Holler, E. and Andreesen, R. and Hildebrandt, G. C. (2010) Steroid treatment alters adhesion molecule and chemokine expression in experimental acute graft versus host disease of the intestinal tract. ONKOLOGIE, 33 (Suppl6). p. 264. ISSN 0378-584X

Bruns, H. and Busch, L. and Boettcher, M. and Mougiakakos, D. and Bittenbring, J. T. and Nolting, J. and Bisht, S. and Buettner, M. and Rehli, M. and Wimmer, J. and Volmer, D. and Beier, F. and Gezer, D. and Neumann, F. and Bach, C. and Balzer, H. and Moi, S. and Brossart, P. and Mackensen, A. (2016) Lenalidomide enhances MOR202 dependent macrophage-mediated effector functions via the vitamin D pathway. KARGER, BASEL.

Bruns, H. and Mougiakakos, D. and Bach, C. and Busch, L. and Bittenbring, J. T. and Buettner, M. and Boettcher, M. and Balzer, H. and Bitterer, K. and Gelse, K. and Hennig, F. F. and Rehli, M. and Wimmer, J. and Beier, F. and Gezer, D. and Kroenke, J. and Spriewald, B. and Mackensen, A. (2017) The IKZF1-IRF4 axis regulates macrophage polarization and macrophage-mediated anti-tumor immunity. KARGER, BASEL.

C

Christopeit, M. and Tischer, J. and Schetelig, J. and Bomhaeuser, M. and Uharek, L. and Wolff, D. and Holler, E. and Pfrepper, C. and Behre, G. and Niederwieser, D. and Kroeger, N. and Kobbe, G. and Weber, T. and Mueller, L. P. and Roesler, W. and Klein, S. and Hausmann, A. and Beelen, D. W. and Bethge, W. and Schmid, C. (2016) Haploidentical second allogeneic hematopoietic stem cell transplantation for the treatment of acute leukemia relapse after first allo-HSCT: An updated retrospective registry analysis of 69 pts on behalf of the German Cooperative Transplant Group. KARGER, BASEL.

D

Derigs, P. and Bethge, W. and Holtick, U. and Von Tresckow, B. and Ayuk, F. and Penack, O. and Vucinic, V. and Von Bonin, M. and Baldus, C. and Mougiakakos, D. and Wulf, G. and Schnetzke, U. and Stelljes, M. and Thomas, S. and Schroers, R. and Kroeger, N. and Dreger, P. (2022) Factors associated with long-term survival after failure a chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory large B-cell lymphomas:a role for allogeneic stem cell transplantation? In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Dietz, C. T. and Kalmanti, L. and Fabarius, A. and Lauseker, M. and Haferlach, C. and Schlegelberger, B. and Jotterand, M. and Mueller, M. C. and Haenel, M. and Koehne, C-H and Goebeler, M. -E and Pfreundschuh, M. and Balleisen, L. and Burchert, A. and Krause, S. W. and Edinger, M. and Pfirrmann, M. and Hasford, J. and Hochhaus, A. and Saussele, S. and Hehlmann, R. (2015) Impact of unbalanced major and minor route karyotypes at diagnosis on prognosis of CML. KARGER, BASEL.

Ditz, D. and Ammer, J. and Landfried, K. and Schmidhuber, J. and Holler, B. and Wolff, D. and Andreesen, R. and Holler, E. (2012) Everolimus in chronic graft-versus-host-disease - a single centre experience. ONKOLOGIE, 35 (suppl6). pp. 208-209. ISSN 0378-584X

Doering, J. and Fante, M. and Kattner, A.-S. and Kaiser, U. and Weber, D. and Holler, B. and Poeck, H. and Holler, E. and Herr, W. and Edinger, M. and Wolff, D. (2022) Atypical manifestations of chronic graft-versus-host disease - a retrospective unicentric analysis. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

E

Edinger, M. and Mackensen, A. and Einsele, H. and Herr, W. (2023) Collaborative Research Centre/Transregio 221: modulation of graft-versus-host and graft-versus-leukemia immune responses after allogeneic stem cell transplantation. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Eichholz, L. and Herr, W. and Hauptrock, B. and Kolbe, K. and Meyer, R. G. and Theobald, M. and Wagner, E. M. (2014) Prophylactic CD8-depleted DLI or preemptive CD3pos DLI? - On the way to an individualized immunotherapy after allogeneic HSCT. KARGER, BASEL.

Eichler, Martin and Andreou, Dimosthenis and Golcher, Henriette and Hentschel, Leopold and Richter, Stephan and Hohenberger, Peter and Kasper, Bernd and Pink, Daniel and Jakob, Jens and Ashmawy, Hany and Hettmer, Simone and Tuchscherer, Armin and Grube, Matthias and Heidt, Vitali and Jentsch, Christina and Pablik, Jessica and Wardelmann, Eva and Kreitner, Karl-Friedrich and Kneser, Ulrich and Tonus, Carolin and Wimberger, Pauline and Schoffer, Olaf and Reichardt, Peter and Wartenberg, Markus and Eberlein-Gonska, Maria and Bornhauser, Martin and Schmitt, Jochen and Schuler, Markus K. (2021) Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study. ONCOLOGY RESEARCH AND TREATMENT, 44 (6). pp. 301-312. ISSN 2296-5270, 2296-5262

Eickmann, S. and Wolff, D. and Kobbe, G. and Dreger, P. and Kroeger, N. and Herrmann, A. (2021) Development of strategies to increase the uptake of continuing medical education in stem cell transplantation - a qualitative study. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Eickmann, S. and Wolff, D. and Kobbe, G. and Dreger, P. and Kroeger, N. and Herrmann-Johns, A. (2023) What do expect residents from continuous medical education? - A qualitative study of hemato-oncology physicians. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Eickmann, Sascha and Wolff, Daniel and Kobbe, Guido and Dreger, Peter and Kroeger, Nicolaus and Herrmann-Johns, Anne (2024) Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of Physicians. ONCOLOGY RESEARCH AND TREATMENT, 47 (4). pp. 136-144. ISSN 2296-5270, 2296-5262

Enssle, S. and Perl, M. and Nedelko, T. and Krieger, M. and Bassermann, F. and Poeck, H. and Heidegger, S. (2021) Tumor cell-intrinsic Gasdermin E (GSDME) activation contributes to checkpoint inhibitor-mediated anticancer immunity. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Evers, G. and Beelen, D. W. and Braess, J. and Sauerland, M. C. and Kolb, H. J. and Reichle, A. and Holler, E. and Schwerdtfeger, R. and Arnold, R. and Scheid, C. and Krug, U. and Mueller-Tidow, C. and Schliemann, C. and Mikesch, J. -H. and Lenz, G. and Woermann, B. J. and Hiddemann, W. and Berdel, W. E. and Stelljes, M. (2018) Allogeneic hematopoietic stem cell transplantation (HSCT) beyond first complete remission (CR) in patients with acute myeloid leukemia (AML): Results from the AMLCG1999 trial. KARGER, BASEL.

F

Fante, M. A. and Doering, J. and Angstwurm, K. and Banas, B. and Schulz, C. and Hamer, O. W. and Herr, W. and Edinger, M. and Wolff, D. and Perl, M. (2023) Atypical cGvHD manifestations: a retrospective analysis of prevalence, risk factors and impact on survival. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Fante, M. A. and Harrer, D. C. and Felsenstein, M. and Zartner, B. and Lueke, F. and Mayer, S. and Reichle, A. and Herr, W. and Vogelhuber, M. and Heudobler, D. (2023) All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T cell lymphoma and relapsed/refractory aggressive B cell lymphoma. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Flamann, C. and Matos, C. and Kreutz, M. and Buettner-Herold, M. and Shaikh, H. and Beilhack, A. and Voelkl, S. and Zeun, J. and Kremer, A. and Kellner, C. and Ekici, A. and Bitterer, K. and Leffler, M. and Saul, D. and Mougiakakos, D. and Mackensen, A. and Bruns, H. (2021) Regulation of the immune balance by vitamin D-3 during allogeneic hematopoietic stem cell transplantation. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Flamann, C. and Matos, Carina and Kreutz, Marina and Shaikh, H. and Beilhack, A. and Buettner-Herold, M. and Lischer, C. and Voelkl, S. and Kellner, C. and Zeun, J. and Kremer, A. and Bitterer, K. and Saul, D. and Mougiakakos, D. and Mackensen, A. and Bruns, H. (2022) Increased CD47 expression inhibits phagocytosis of alloreactive donor T cells after allo-HSCT. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Flamann, C. and Shaikh, H. and Matos, C. and Kreutz, M. and Buettner-Herold, M. and Lischer, C. and Voelkl, S. and Kellner, C. and Zeun, J. and Kremer, A. and Bitterer, K. and Saul, D. and Mougiakakos, D. and Beilhack, A. and Mackensen, A. and Bruns, H. (2023) Enhanced CD47 expression inhibits phagocytic clearance of alloreactive donor T cells after allo-HSCT. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Flamann, C. and Zeun, J. and Kremer, A. and Voelkl, S. and Peter, K. and Kreutz, M. and Buettner-Herold, M. and Kellner, C. and Saul, D. and Mougiakakos, D. and Mackensen, A. and Bruns, H. (2020) Immune cell regulation by vitamin D-3 during allogeneic hematopoietic stem cell transplantation (HSCT). In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Foell, J. and Wolff, D. and Pfirstinger, B. and Rehe, K. and Holler, E. and Corbacioglu, S. (2017) Treosulfan based conditioning regimen for stem cell transplantation with matched sibling bone marrow or haploidentical CD3(+)/19(+) depleted PBSC for advanced stage sickle cell disease. KARGER, BASEL.

Fuchs, M. and Wongso, D. and Pluetschow, A. and Feuring-Buske, M. and Hertenstein, B. and Hoeffkes, H. -G and Vogelhuber, M. and von Tresckow, B. and Biersack, H. and Link, H. and Topp, M. S. and Fischer, N. and Bredenfeld, H. and Sasse, S. and Behringer, K. and Boell, B. and Borchmann, P. and Engert, A. (2014) Final analysis of a randomized phase II trial with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma -PVAG-14 pilot-. KARGER, BASEL.

G

Gaerditz, S. and Mayer, S. and Grube, M. and Hahn, J. and Authier, D. and Marquardt, K. and Herr, W. (2020) Acral necrosis as an unusual end-organ damage in multiple myeloma. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Goettert, S. and Thiele-Orberg, E. and Fan, K. and Ghimire, S. and Mamilos, A. and Bassermann, F. and Herr, W. and Heidegger, S. and Holler, E. and Poeck, H. (2023) Immunomodulatory microbial metabolites identified in allo-SCT patients protect from GVHD by STING dependent modulation of intestinal tissue homeostasis. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Gottfried, E. and Ugele, I. and Conejoe, Cardenas E. and Wehrstein, M. and Thomas, S. and Herr, W. and Kreutz, M. (2014) 2-Hydroxyglutarate reduces IL-12 production of human dendritic cells. KARGER, BASEL.

Grassinger, J. and Cao, B. and Zhang, Z. and Klatt, S. and Williams, B. and Mueller, G. and Hart, C. and Schelker, R. and Herr, W. and Nilsson, S. K. (2015) Effective mobilization of hematopoietic stem cells with a small molecule alpha 9 beta 1/alpha 4 beta 1 integrin antagonist. KARGER, BASEL.

Grassinger, J. and Storan, M. and Williams, B. and Olsen, G. and Haylock, D. N. and Nilsson, S. K. (2010) Homing, proliferation and mobilization of hematopoietic stem cells is regulated through the interaction of alpha(9)beta(1) and Osteopontin. ONKOLOGIE, 33 (Suppl6). p. 217. ISSN 0378-584X

Greuter, Thomas and Lang, Silvia and Holler, Ernst and Hawkey, Christopher J. and Rogler, Gerhard and Biedermann, Luc (2015) Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing lmmunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC Trial. DIGESTION, 92 (2). pp. 83-89. ISSN 0012-2823, 1421-9867

Göttert, S. and Thiele Orberg, E. and Fan, K. and Ghimire, S. and Meedt, Elisabeth and Haller, D. and Heidegger, S. and Holler, E. and Poeck, Hendrik (2022) Microbial Metabolites induce epithelial Regeneration by Activating the STING Signaling Pathway in Mice and Humans and protect against Graft versus Host Disease. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

H

Haanen, J. B. and Mackensen, A. and Koenecke, C. and Alsdorf, W. and Wagner-Drouet, E. and Heudobler, Daniel and Borchmann, P. and Klobuch, S. and Smit, E. and Bokemeyer, C. and Desuki, A. and Lüke, Florian and Wiegert, E. and Schulz-Eying, C. and Rengstl, B. and Preussner, L. and Türeci, Ö. and Sahin, U. (2022) BNT211: a Phase 1 Study to determine the Safety and Efficacy of CLDN6 CAR T Cells and CARVAC-mediated in vivo Expansion in Patients with CLDN6-positive advanced solid Tumors. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Hammon, K. and Cardenas-Conejo, Z. E. and Dettmer, K. and Oefner, P. and Herr, W. and Renner, K. and Kreutz, M. and Thomas, S. (2017) The tumor-derived oncometabolite D-2-Hydroxyglutarate alters the immune phenotype as well as mitochondrial activity of monocyte-derived dendritic cells. KARGER, BASEL.

Hammon, K. and Renner-Sattler, K. and Thomas, S. and Kreutz, M. (2022) The onco metabolite hydroxyglutarate supports an anti-glycolytic Warburg phenotype with low MHC class II expression. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Harrer, D. C. and Jakob, M. and Vogelhuber, M. and Lueke, F. and Rehe, K. and Corbacioglu, S. and Herr, W. and Reichle, A. and Heudobler, D. (2020) Biomodulatory therapy induces long-lasting remissions in chemorefractory multi-system Langerhans cell histiocytosis. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Hart, C. and Barop, J. and Mueller, G. and Schelker, R. and Herr, W. and Holler, E. and Grassinger, J. (2014) Factors influencing the engraftment in patients with myelofibrosis after allogeneic stem cell transplantation. KARGER, BASEL.

Hart, C. and Mueller, G. and Raithel, J. and Andreesen, R. and Grassinger, J. (2011) Phenotypical and functional characterization of cell subtypes from bone marrow samples of patients with acute myeloid leukemia. ONKOLOGIE, 34 (Suppl6). p. 197. ISSN 0378-584X

Hart, C. and Mueller, G. and Raithel, J. and Williams, B. and Andreesen, R. and Nilsson, S. K. and Grassinger, J. (2012) Homing and engraftment of murine and human hematopoietic stem and progenitor cells are mediated by junctional adhesion molecule A. ONKOLOGIE, 35 (suppl6). pp. 100-101. ISSN 0378-584X

Hart, C. and Vogelhuber, M. and Wolff, D. and Klobuch, S. and Ghibelli, L. and Foell, J. and Corbacioglu, S. and Rehe, K. and Haegeman, G. and Thomas, S. and Herr, W. and Reichle, A. (2015) Anakoinosis: Communicative reprogramming of tumor systems - for rescuing chemorefractory neoplasia. KARGER, BASEL.

Hart, Christina (2022) New Data and Recommendations for VTE Primary Prophylaxis in Cancer Patients. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Hau, Peter and Kunz-Schughart, L. and Bogdahn, U. and Baumgart, U. and Hirschmann, B. and Weimann, E. and Muehleisen, H. and Ruemmele, P. and Steinbrecher, A. and Reichle, A. (2007) Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-Gamma Agonists in recurrent high-grade gliomas - A phase II study. ONCOLOGY, 73 (1-2). pp. 21-25. ISSN 0030-2414

Hausmann, M. and Zeitler, C. and Weber, A. and Krebs, M. and Kellermeier, S. and Rosenstiel, P. and de Valliere, C. and Kosovac, K. and Fried, M. and Holler, E. and Rogler, G. (2012) MIP-3 alpha Expression in Macrophages Is NOD Dependent. DIGESTION, 85 (3). pp. 192-201. ISSN 0012-2823

Hautmann, A. H. and Schroeder, J. and Wild, P. and Hautmann, M. and Hoffstetter, P. and Girlich, C. and Fleck, M. (2014) Tumor-induced osteomalacia: increased level of FGF-23 in a patient with a mesenchymal giant cell tumor at the tibia expressing Periostin. KARGER, BASEL.

Hautmann, A. H. and Wolff, D. and Hilgendorf, I and Fehn, U. and Edinger, M. and Herr, W. and Koelbl, O. and Holler, B. and Sporrer, D. and Holler, E. and Hautmann, M. G. (2014) Total nodal irradiation in patients with severe and mostly corticosteroid-refractory chronic graft-versus-host-disease after allogeneic stem cell transplantation. KARGER, BASEL.

Heidenreich, M. and Herr, W. and Vogelhuber, M. and Hahn, J. and Hellwig, D. and Menhart, K. and Rennert, J. and Beutl, M. and Weber, F. and Koelble, K. and Gad, B. (2021) Relapse of Hodgkin's disease with CNS involvement: Case report on successful relapse therapy. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Heinzelmann, F. and Bethge, W. and Beelen, D. W. and Niederwieser, D. and Dreger, P. and Finke, J. and Bunjes, D. and Dreyling, M. and Kobbe, G. and Kroeger, N. and Holler, E. and Bornhaeuser, M. and Mueller, A. and Haubitz, I and Schrezenmeier, H. and Mueller, C. and Ottinger, H. (2013) Allogeneic haematopoietic cell transplantation offers a substantial chance of cure for patients with non-transformed follicular lymphoma even when presenting with chemotherapy-resistant disease at time of transplant. KARGER, BASEL.

Held, G. and Poeschel, V and Altmann, B. and Illmer, T. and Andre, M. and Dreyling, M. and Maisonneuve, H. and Tilly, H. and Mayer, S. and Casasnovas, R. -O and Le Gouill, S. and Offner, F. C. and Cartron, G. and Kerkhoff, A. and Weber, T. and Hoffmann, J. and Ziepert, M. and Klapper, W. and Itti, E. and Hellwig, D. and Natchkebia, G. and De Leval, L. and Rosenwald, A. and Haioun, C. and Dercle, L. and Gaulard, P. and Houot, R. (2021) Nivolumab in combination with Gemcitabine and Oxaliplatin (GemOx) in Relapse/Refractory T-cell Lymphoma: Preliminary results of the experimental arm of the NIVEAU trial. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Herr, W. (2014) Biology of allogeneic stem cell transplantation: GvH - GvL reaction. KARGER, BASEL.

Herr, W. (2016) Prediction of immune response in hematologic and solid tumors. KARGER, BASEL.

Herrmann, A. and Wolff, D. and Holler, E. and Edinger, M. and Pukrop, T. and Herr, W. and Hall, A. and Zdenkowski, N. and Sanson-Fisher, R. (2023) Development of innovative strategies for optimal patient-centred communication with cancer patients and support persons - A comprehensive mixed-methods approach. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Heudobler, D. and Haferkamp, S. and Seidl, A.-P. and Hart, C. and Loquai, C. and Weishaupt, C. and Sell, S. and Schultz, E. and Lueke, F. and Mayer, S. and Vogelhuber, M. and Herr, W. and Reichle, A. (2023) A prospective phase I and consecutive phase II, two-arm, randomized multi-center trial of temsirolimus in combination with pioglitazone, etoricoxib and metronomic low-dose trofosfamide versus dacarbazine (DTIC) in patients with advanced melanoma (MEL001). In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Heudobler, D. and Klobuch, S. and Hahn, J. and Thomas, S. and Herr, W. and Reichle, A. (2018) Cutaneous leukemic infiltrates successfully treated with biomodulatory therapy in a rare case of therapy-related high risk MDS/AML. KARGER, BASEL.

Heudobler, D. and Lueke, F. and Hahn, J. and Grube, M. and Schlosser, P. and Kremers, S. and Suedhoff, T. and Westermann, J. and Huetter-Kroenke, M. L. and Weber, D. and Paschka, P. and Zeman, F. and Doehner, H. and Herr, W. and Thomas, S. and Reichle, A. (2021) Low-dose Azacitidine, Pioglitazone and All-trans Retinoic Acid versus standard-dose Azacitidine in patients >= 60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): Results of the safety run-in phase. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Heudobler, D. and Lueke, F. and Herr, W. and Reichle, A. (2018) Biomodulatory treatment induces long-term remission in advanced angiosarcoma. KARGER, BASEL.

Heudobler, D. and Rechenmacher, M. and Vogelhuber, M. and Thomas, S. and Pukrop, T. and Hackl, C. and Herr, W. and Ghibelli, L. and Gerner, C. and Reichle, A. (2018) A novel therapeutic pillar, anakoinosis: Tumor tissue as a multi-level design space, a meta-analysis. KARGER, BASEL.

Heudobler, D. and Villanueva, L. and Lwin, Z. and Chung, H. C. and Gomez-Roca, C. and Munoz, F. L. and Yanez, E. and Senellart, H. and Doherty, M. and Garcia-Corbacho, J. and Hendifar, A. E. and Maurice-Dror, C. and Gill, S. and Kim, T. W. and Penel, N. and Ghori, R. and Kubiak, P. and Jin, F. and Norwood, K. and Graham, D. (2021) Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase 2 LEAP005 study. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Heudobler, Daniel and Schulz, Christian and Illerhaus, G. and Janning, M. and Griesinger, F. and Lüke, Florian and Herr, Wolfgang and Pukrop, Tobias (2022) A prospective, open-label, multi-centre phase II study to investigate the safety and efficacy of a combination therapy with nivolumab, ipilimumab and bevacizumab together with 2 cycles of induction chemotherapy in patients with non-squamosisNSCLC with brain metastases (CA209-7WF/Break B5). In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Hierl, Marina and Pfirstinger, Jochen and Andreesen, Reinhard and Holler, Ernst and Mayer, Stephanie and Wolff, Daniel and Vogelhuber, Martin (2017) Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology Patients. ONCOLOGY, 93 (3). pp. 157-163. ISSN 0030-2414, 1423-0232

Hildebrandt, M. and Apperley, J. and Dickinson, A. M. and Edinger, M. and Greinix, H. and Hauser, A. and Koehl, U. and Mischak-Weissinger, E. and Pearce, K. F. and Scheding, S. and Worel, N. and Lowdell, M. W. (2013) The Regulation of Advanced Therapy Medicinal Products (ATMPs) in Europe and the Role of Academia: Results of an FP7-funded Research Project. KARGER, BASEL.

Hilgendorf, I. and Greinix, H. and Halter, J. and Ayuk, F. and Wagner, E. -M and Lindner, B. and Gleich, S. and Hochhaus, A. and Wolff, D. (2016) The JETS-project of the German-Austrian-Swiss GVHD Consortium - a prospective study of late effects in adolescent and young adults after stem cell transplantation. KARGER, BASEL.

Hilgendorf, I. and Jilg, W. and Einsele, H. and Greinix, H. and Halter, J. and Freund, M. and Lawitschka, A. and Wolff, D. and Meisel, R. (2010) Vaccination of haematopoietic stem cell transplant recipients: Report from the International Consensus Conference on Clinical Practice in chronic GVHD. ONKOLOGIE, 33 (Suppl6). p. 28. ISSN 0378-584X

Hilgendorf, I. and Kramer, M. and Heussner, P. and Herzberg, P. Y. and Freund, M. and Wolff, D. (2012) Impaired endurance of younger adults - is physiotherapy "out and uncool"? ONKOLOGIE, 35 (suppl6). p. 226. ISSN 0378-584X

Hilgendorf, I. and Pulewka, K. and Herzberg, P. Y. and Greinix, H. and Heussner, P. and Mumm, F. and von Harsdorf, S. and Rieger, K. and Hemmati, P. and Holler, E. and Hochhaus, A. and Wolff, D. (2016) Adolescent and young adults versus older adults in the setting of allogeneic stem cell transplantation - two cohorts with special needs. KARGER, BASEL.

Hilgendorf, I. and Rocke, P. and Wolff, D. and Sockel, K. and Midekke, J. M. and Heidenreich, D. and Schaefer-Eckart, K. and Wagner-Drouet, E. and Frietsch, J. J. and Hochhaus, A. (2023) Late effects after allogeneic hematopoietic stem cell transplantation in young adults in Germany - a prospective, multicenter trial. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Hilgendorf, Inken and Wolff, Daniel and Nogai, Axel and Kundt, Guenther and Hahn, Joachim and Holler, Ernst and Uharek, Lutz and Junghanss, Christian and Leithaeuser, Malte and Thiel, Eckhard and Freund, Mathias and Kahl, Christoph (2012) Chronic Graft versus Host Disease but not the Intensity of Conditioning Has Impact on Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Hematological Diseases. ONKOLOGIE, 35 (9). pp. 487-492. ISSN 0378-584X

Hoepting, Matthias and Budde, Ulrich and Tiede, Andreas and Grube, Matthias and Hahn, Joachim and Herr, Wolfgang and Heimerl, Susanne and Hart, Christina (2022) Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient. ACTA HAEMATOLOGICA, 145 (4). pp. 454-457. ISSN 0001-5792, 1421-9662

Holler, E. (2014) The role of the microbiome in the pathophysiology of GvHD. KARGER, BASEL.

Holler, E. and Landfried, K. and Zhu, W. and Waldbier, M. and Schulz, U. and Ammer, J. and Holler, B. and Wolff, D. and Edinger, M. and Kreutz, M. and Andreesen, R. and Oefner, P. (2011) Reactive release of tryptophan metabolites in early complications of human stem cell transplantation indicates activation of IDO. ONKOLOGIE, 34 (Suppl6). p. 279. ISSN 0378-584X

Holler, E. and Weber, D. and Hiergeist, A. and Gessner, A. (2017) The role of the intestinal microbiome in GvHD. KARGER, BASEL.

Holler, E. and Zhu, W. and Landfried, K. and Peter, K. and Kreutz, M. and Ammer, J. and Holler, B. and Wolff, D. and Edinger, M. and Andreesen, R. and Oefner, P. (2012) Indoxyl sulfate as a marker of intestinal bacterial diversity in patients receiving allogeneic stem cell transplantation: Impact of antibiotic treatment and intestinal GvHD. ONKOLOGIE, 35 (suppl6). p. 158. ISSN 0378-584X

Hullard-Pulstinger, Annette and Holler, Ernst and Hahn, Joachim and Andreesen, Reinhard and Krause, Stefan W. (2011) Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia. ONKOLOGIE, 34 (5). pp. 254-258. ISSN 0378-584X

Hummel, S. and Heudobler, D. and Mueller-Newen, G. and Huber, E. and Ziegler, P. and Jost, E. and Bruemmendorf, T. H. and Holler, E. and Beier, F. (2013) Enterocytes of patients with uncontrolled acute graft versus host disease of the gut undergo massive telomere shortening compared to unaffected controls. KARGER, BASEL.

I

Illerhaus, G. and Cwynarski, K. and Pulczynski, E. and Ponzoni, M. and Deckert, M. and Politi, L. S. and Fox, C. P. and La Rose, P. and Ambrosetti, A. and Roeth, A. and Hemmaway, A. and Ilariucci, F. and Linton, K. M. and Soffietti, R. and Pukrop, T. and Binder, M. and Balzarotti, M. and Fabbri, A. and Johnson, P. and Gorlov, J. S. and Cavalli, F. and Finke, J. and Schorb, E. and Reni, M. and Zucca, E. and Ferrer, A. J. M. (2015) Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial. KARGER, BASEL.

J

Jacob, Anne Sophie and Fuchs, Michael and Kaul, Helen and Kobe, Carsten and Pabst, Thomas and Greil, Richard and Eichenauer, Dennis and Topp, Max and Just, Marianne and Hertenstein, Bernd and Schaub, Valdete and Vogelhuber, Martin and Zijlstra, Josee M. and Pluetschow, Annette and Baues, Christian and Rosenwald, Andreas and Dietlein, Markus and Borchmann, Peter and Engert, Andreas (2022) PET-Guided Treatment in Patients with Early-Stage Favorable Hodgkin Lymphoma: Follow-up Analysis of the HD16 Trial by the German Hodgkin Study Group. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.

Joachim, L. and Goettert, S. and Sax, A. and Steiger, K. and Neuhaus, K. and Kleigrewe, K. and Thiele-Orberg, E. and Heidegger, S. and Poeck, H. (2023) The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with anti-CTLA-4. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

K

Kaiser, F. and Vehling-Kaiser, U. and Kaiser, F. and Hoffmann, A. and Fiedler, M. and Koller, M. and Rechenmacher, M. and Kaiser, U. (2023) Investigation into the implementation, realization, and benefits of a day hospice - A study protocol. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Kaiser, U. and Evert, K. and Vehling-Kaiser, U. and Lueke, F. and Herr, W. and Rechenmacher, M. (2023) Developing a structured program to perform targeted autopsies to better understand the mechanisms of tumor metastasis. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Kaiser, U. and Vehling-Kaiser, U. and Hoffmann, A. and Bochnia-Rieder, B. and Kaiser, F. (2021) Surviving with metastatic apocrine carcinoma of the sweat glands - made possible by molecular pathology. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Kaiser, U. and Vehling-Kaiser, U. and Kaiser, F. and Hoffmann, A. and Fiedler, M. and Hofbauer, A. and Koller, M. and Rechenmacher, M. and Kaiser, F. (2023) TGHS11 and TGHS14-two newly developed questionnaires for patients of a day hospice and their relatives. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Kaiser, U. and Vehling-Kaiser, U. and Kalteis, M. and Kaiser, F. (2020) Using rain ponchos against viruses - Specialised outpatient palliative care (SAPV) during the Covid-19 pandemic. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Kaiser, U. and Woermann, B. and Kaiser, F. and Woehr, M. and Oldenburg, M. and Hoffmann, A. and Damnali, G. and Heinecke, S. and Osburg, S. and Binder, C. and Bochnia-Rieder, B. and Fiedler, M. and Vehling-Kaiser, U. (2022) The COVID-19 Flyer for Patients from Hematology and Oncology - Published by the Working Group on Patient Safety and Patient Adherence of the DGHO. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Kaiser, Ulrich and Rieger, L. and Holzapfel, K. and Kaiser, F. and Damnali, G. and Bochnia-Rieder, B. and Vehling-Kaiser, U. (2022) Long-term survival in multiple metastatic cervical cancer-12 years after administration of paclitaxel/topotecan/bevacizumab. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Kattner, A.-S. and Holler, E. and Weber, M. and Weber, D. and Burkhardt, R. and Edinger, M. and Herr, W. and Wolff, D. (2021) Protracted lymphocyte regeneration after allogeneic hematopoietic stem cell transplantation with ATG as GvHD prophylaxis is associated with increased TRM independent of occurrence of GvHD. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Kern, M. and Le, D.-D. and Shaikh, H. and Gomez de Agüero, M. and Hoenicke, L. and Strowig, T. and Falk, N. and Hoffmann, P. and Beilhack, A. (2021) Microbial stimuli are important for maintaining immunomodulatory macrophages during the effector phase of intestinal aGvHD. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Kipshagen, J. and Pfirstinger, J. and Boeger, M. and Girbig, M. and Holler, E. and Lehmke, B. and Schoen, I and Wolff, D. and Andreesen, R. and Vogelhuber, M. (2011) Predictive factors for the need of child centered counseling in parents with cancer - results from a single center analysis. ONKOLOGIE, 34 (Suppl6). p. 126. ISSN 0378-584X

Klobuch, S. and Steinberg, T. and Reichle, A. and Herr, W. and Thomas, S. (2016) Biomodulatory therapy with low-dose azacitidine, pioglitazone and ATRA induces myeloid differentiation and phagocytosis in primary AML blasts. KARGER, BASEL.

Klobuch, S. and Wandel, A. and Vatter, S. and Zwerger, M. and Mirbeth, C. and Herr, W. and Thomas, S. (2018) T cells modified with an allo-HLA-DPB1 specific TCR and an enhanced EGFRt safety switch induce potent anti-leukemia reactivity in vitro as well as in a xenograft mouse model. KARGER, BASEL.

Klobuch, Sebastian and Weber, Daniela and Holler, Barbara and Herr, Wolfgang and Holler, Ernst and Wolff, Daniel (2017) Potential Role of the PD-1/PD-L1 Axis in the Immune Regulation of Chronic GVHD. ONCOLOGY RESEARCH AND TREATMENT, 40 (7-8). pp. 447-450. ISSN 2296-5270, 2296-5262

Knoedler, M. and Gauler, T. C. and Gruenwald, V. and Matzdorff, A. and Schroeder, M. and Dietz, A. and Jordan, W. -O. and Arnold, D. and Hennemann, B. and Hofele, C. and Weissinger, F. and Eberhardt, W. and Keilholz, U. (2013) Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie. ONCOLOGY, 84 (5). pp. 284-289. ISSN 0030-2414

Knop, S. and Langer, C. and Engelhardt, M. and Muegge, L-O and Roesler, W. and Reichle, A. and Roellig, C. and Hertenstein, B. and Gramatzki, M. and Bassermann, F. and Ostermann, H. and Sturm, I and Ringhoffer, M. and Schaefer-Eckart, K. and Falk, K. and Liebert, A. and Einsele, H. and Bargou, R. (2013) Lenalidomide, Adriamycin, Dexamethasone (RAD) followed by risk-adjusted transplant is a novel and very effective induction regimen in newly diagnosed multiple myeloma. KARGER, BASEL.

Knop, S. and Langer, C. and Engelhardt, M. and Stuebig, T. and Schreder, M. and Dechow, T. and Muegge, L. -O. and Bassermann, F. and Schaefer-Eckart, K. and Blau, I. -W. and Wolleschak, D. and Kropff, M. and Reichle, A. and von Metzler, I. and Metzner, B. and Roellig, C. and Hertenstein, B. and Pfreundschuh, M. and Duerk, H. and Biersack, H. and Ostermann, H. and Menzel, H. and Schleicher, J. and Gramatzki, M. and Gerecke, C. and Mueller, M. and Brueggemann, M. and Held, S. and Einsele, H. (2017) Lenalidomide, adriamycin and dexamethasone (RAD) versus bortezomib, lenalidomide and dexamethasone (VRD) as induction regimens in newly diagnosed multiple myeloma - first results from the DSMM XIV study. KARGER, BASEL.

Knop, S. and Liebisch, P. and Hebart, H. and Holler, E. and Engelhardt, M. and Bargou, R. C. and Metzner, B. and Doelken, G. and Peest, D. and Aulitzky, W. and Bunjes, D. and Straka, C. and Wandt, H. and Sezer, O. and Hentrich, M. and Ostermann, H. and Dechow, T. and Hess, G. and Hertenstein, B. and Freund, M. and Kropff, M. and Wolf, H. and Jung, W. and Frickhofen, N. and Maschmeyer, G. and Mergenthaler, H. and Kanz, L. and Meisner, C. and Einsele, H. (2011) Up front allogeneic stem cell transplant is superior to tandem high-dose melphalan in cytogenetically defined ultra high-risk myeloma. ONKOLOGIE, 34 (Suppl6). pp. 199-200. ISSN 0378-584X

Knödler, L. and Perl, M. and Becker, L. and Herr, W. and Schmidl, C. and Poeck, H. (2022) Overcoming CAR-T cell depletion and improving antitumor efficacy in hematologic neoplasia by polyclonal genomic modification. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Koch, T. and Korn, K. and Lang, V and Zeun, J. and Graw, F. and Voelkl, S. and Thomas, S. and Mackensen, A. and Kremer, A. and Reimann, H. (2023) Identification of CD4+T Cells targeting DM-sensitive Antigens in mismatched HLA-DP Alleles as Mediators for selective Graftversus-Leukemia Effect. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Krause, C. and Herzberg, P. Y. and Pavletic, S. Z. and Heussner, P. and Mumm, F. and Balsiger, C. and Hilgendorf, I and Hemmati, P. and von Harsdorf, S. and Herr, W. and Holler, E. and Greinix, H. and Mitchell, S. A. and Wolff, D. (2014) Comorbidity significantly impairs quality of life in patients after allogeneic hematopoietic stem cell transplantation - results from the prospective german multicenter validation trial. KARGER, BASEL.

Krekeler, Carolin and Irmer, Barnabas and Sivaloganathan, Suganja and Menck, Kerstin and Peeck, Micha and Wlochowitz, Darius and Conradi, Lena-Christin and Wachter, Astrid and Bayerlova, Michaela and Wolff, Alexander and Schildhaus, Hans-Ulrich and Stadelmann-Nessler, Christine and Proescholdt, Martin and Homayounfar, Kia and Pukrop, Tobias and Beissbarth, Tim and Bleckmann, Annalen (2022) Molecular consensus subtyping of colorectal carcinoma In liver and brain metastases. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.

Kriegsmann, Katharina and Bittrich, Max and Sauer, Sandra and Tietze-Stolley, Carola and Movassaghi, Kamran and Grube, Matthias and Vucinic, Vladan and Wehler, Daniela and Burchert, Andreas and Schmidt-Hieber, Martin and Rank, Andreas and Duerk, Heinz A. and Metzner, Bernd and Kimmich, Christoph and Hentrich, Marcus and Kunz, Christian and Hartmann, Frank and Khandanpour, Cyrus and de Wit, Maike and Holtick, Udo and Kiehl, Michael and Stoltefuss, Andrea and Kiani, Alexander and Naumann, Ralph and Scholz, Christian W. and Tischler, Hans-Joachim and Goerner, Martin and Brand, Franziska and Ehmer, Martin and Kroeger, Nicolaus (2023) Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study. TRANSFUSION MEDICINE AND HEMOTHERAPY, 50 (5). pp. 403-416. ISSN 1660-3796, 1660-3818

Kroeger, I and Meinhardt, K. and Abendroth, A. and Rehli, M. and Mackensen, A. and Ullrich, E. (2011) Functional role of different NK cell subpopulations in GVHD. ONKOLOGIE, 34 (Suppl6). p. 273. ISSN 0378-584X

Kroeger, Nicolaus and Bittrich, Max and Vucinic, Viadan and Grube, Matthias and Hentrich, Marcus and de Wit, Maike and Kunz, Christian and Metzner, Bernd and Humpe, Andreas (2020) Non-Interventional Optimob-Study: a Nationwide Evaluation of Mobilization and Collection of Hematopoietic Stem and Progenitor Cells in Patients with Multiple Myeloma (MM) and Lymphoma in Clinical Practice. In: 34. Deutscher Krebskongress (DKK), 19.-22. Februar 2020, Berlin.

Kuchlbauer, S. and Wolff, D. and Ammer, J. and Landfried, K. and Holler, B. and Hahn, J. and Edinger, M. and Andreesen, R. and Holler, E. (2011) Rituximab in treatment of cGvHD - results from a retrospective single center analysis. ONKOLOGIE, 34 (Suppl6). pp. 276-277. ISSN 0378-584X

Kutny, D. and Ditz, D. and Wiesinger, I. and Haferkamp, S. and Pukrop, T. (2017) Very good clinical response to brain metastases of metastatic uveal melanoma under pembrolizumab therapy. KARGER, BASEL.

L

Lamby, P. and Mielke, S. and Grigoleit, G. -U. and Ljungman, P. and Hilgendorf, I. and Holler, E. and Holler, B. and Weber, D. and Herr, W. and Graf, S. and Prantl, L. and Dolderer, J. and Bjornhagen-Safwenberg, V. and Wolff, D. (2018) Allogeneic donor skin grafts for treatment of refractory ulcers in cutaneous chronic Graft-versus-Host Disease after allogeneic hematopoietic stem cell transplantation -a retrospective analysis on 7 patients. KARGER, BASEL.

Langer, R. and Lelas, A. and Piekarska, A. and Sadowska-Klasa, A. and Sabol, I. and Desnica, L. and Greinix, H. and Dickinson, A. and Inngjerdingen, M. and Lawitschka, A. and Rittenschober, M. and Vrhovac, R. and Pulanic, D. and Klein, S. and Middeke, J.-M. and Grube, M. and Edinger, M. and Herr, W. and Wolff, D. (2023) Prospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease - an analysis from transplant centers across Europe. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Leidgens, V. and Seliger, C. and Jachnik, B. and Welz, T. and Leukel, P. and Vollmann-Zwerenz, A. and Bogdahn, U. and Kreutz, M. and Grauer, O. M. and Hau, P. (2016) Ibuprofen and diclofenac restrict migration and proliferation of human glioma cell lines in vitro. KARGER, BASEL.

Lieb, Marietta and Madl, Martina and Vogelhuber, Martin and Beckmann, Matthias W. and Erim, Yesim (2024) Psycho-Oncological Self-Help Groups in Bavaria: The Current Situation and Suggestions for Improvement. ONCOLOGY RESEARCH AND TREATMENT, 47 (5). pp. 177-187. ISSN 2296-5270, 2296-5262

Linke, F. and Zaunig, S. and von Bonin, F. and Wilting, J. and Bryja, V and Pukrop, T. and Truemper, L. and Kube, D. (2015) Wnt5a signaling mediates cell migration and invasion of Hodgkin Lymphoma in vitro and in xenograft models. KARGER, BASEL.

Lischer, C. and Eisenhauer, N. and Aigner, M. and Jacobs, B. and Schletter, M. and Gebhard, C. and Rehli, Michael and Bruns, H. and Müller, F. and Mackensen, A. and Gonzalez, Vera J. and Völkl, S. (2022) Single-cell Transcriptome Analysis and clonal Kinetics in a Patient after CD19.CAR-T Cell Therapy. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Lueke, F. and Blazquez, R. and Yamaci, Farioglu R. and Lu, X. and Klein, C. and Pregler, B. and Hannus, S. and Pukrop, T. (2017) Isolated meningeosis: primary tumor detection using single cell analysis of L858R-mutated EGFR. KARGER, BASEL.

Lueke, F. and Harrer, D. C. and Hahn, J. and Grube, M. and Pukrop, T. and Herr, W. and Reichle, A. and Heudobler, D. (2020) Continuous complete remission in two patients with acute lymphoblastic leukemia and severe fungal infection following dose-reduced chemotherapy. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Lueke, F. and Harrer, D. C. and Menhart, K. and Wolff, D. and Holler, E. and Hellwig, D. and Herr, W. and Grube, M. and Vogelhuber, M. and Reichle, A. and Heudobler, D. (2020) Biomodulatory treatment regimen, MEPED, rescues relapsed and refractory classic Hodgkin's disease. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Lueke, F. and Orso, E. and Kirsten, J. and Poeck, H. and Grube, M. and Wolff, D. and Burkhardt, R. and Lunz, D. and Lubnow, M. and Schmidt, B. and Hitzenbichler, F. and Hanses, F. and Salzberger, B. and Evert, M. and Herr, W. and Brochhausen, C. and Pukrop, T. and Reichle, A. and Heudobler, D. (2020) Coronavirus disease 2019 is associated with multi-lineage, morphologic changes in peripheral blood cells. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Lüke, F. and Haller, F. and Spoerl, S. and Gerhard-Hartmann, E. and Utpatel, K. and Kunzmann, V and Chatterjee, M. and Maatouk, I and Bittrich, M. and Einwag, T. and Meidenbauer, N. and Hirsch, D. and Dietmaier, W. and Keil, F. and Scheiter, A. and Immel, A. and Heudobler, D. and Einhell, S. and Kaiser, U. and Maurer, J. and Herrmann, A. and Schenkirsch, G. and Sommer, S. and Jordan, F. and Dintner, S. and Rosenwald, A. and Hartmann, A. and Evert, M. and Maerkl, B. and Bargou, R. and Einsele, H. and Mackensen, A. and Beckmann, M. W. and Pukrop, T. and Herr, W. and Trepel, M. and Goebeler, M.-E. and Claus, R. and Kerscher, A. and Krebs, M. (2023) Screening and measuring patient access to precision oncology in a rural area of Germany - strategic toolbox of the WERA Cancer Center Network. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Lüke, Florian and Haller, F. and Utpatel, K. and Krebs, M. and Meidenbauer, N. and Scheiter, A. and Spörl, S. and Heudobler, Daniel and Keil, F. and Schubart, C. and Tögel, L. and Einhell, S. and Dietmaier, W. and Huss, R. and Dintner, S. and Sommer, S. and Jordan, F. and Goebeler, M. E. and Metz, M. and Haake, D. and Scheytt, M. and Gerhard-Hartmann, E. and Maurus, K. and Braendlein, S. and Rosenwald, A. and Hartmann, A. and Märkl, B. and Einsele, H. and Mackensen, A. and Herr, Wolfgang and Kunzmann, V. and Bargou, R. and Beckmann, M. and Pukrop, Tobias and Trepel, M. and Evert, M. and Claus, R. and Kerscher, A. (2022) Recording of the regional Origin Areas of Patients from the Molecular Tumor Board to Identify the "white Spots" in the Service Area - A joint Initiative of the Bavarian CCC WERA Alliance. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

M

Matos, C. and Peuker, A. and Schoenhammer, G. and Roider, T. and Peter, K. and Ghimire, S. and Herr, W. and Renner, K. and Holler, E. and Kreutz, M. (2021) ATG treatment increases 1,25 (OH)2 vitamin D3 levels in patients undergoing hematopoietic stem cell transplantation. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Meedt, E. and Held, G. and Poeschel, V. and Loher, A. and Luerken, L. and Menhart, K. and Hellwig, D. and Grube, M. and Herr, W. and Mayer, S. (2020) Inflammatory aortitis in a patient with aggressive B-cell lymphoma during treatment within the NIVEAU trial: Gradual re-exposition with Nivolumab, Rituximab, Gemcitabine and Oxaliplatin identifies G-CSF as the provoking agent. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Meier, S. and Kuehl, R. and Baeurle, M. and Wolff, D. and Greinix, H. and Lawitschka, A. and Halter, J. and Bertz, H. and Hilgendorf, I (2018) Exercise therapy for treatment of chronic graft-versus-host disease: recommendations of the German-Austrian-Swiss GvHD consortium. KARGER, BASEL.

Metzgeroth, G. and Schwaab, J. and Naumann, N. and Haferlach, C. and Jawhar, M. and Horny, H. -P. and Dirk, J. and Kratz-Albers, K. and Kraemer, D. and Mayer, S. and Storch, N. and Burchert, A. and Haferlach, T. and Cross, N. C. P. and Hofmann, W. -K. and Fabarius, A. and Reiter, A. (2017) Clinical characteristics and treatment with ruxolitinib in patients with PCM1-JAK2 and BCR-JAK2 positive myeloid/lymphoid neoplasms with eosinophilia. KARGER, BASEL.

Mueller, F. and Schwingen, N. R. and Eisenhauer, N. and Aigner, M. and Schletter, M. and Lutzny-Geier, G. and Lischer, C. and Guese, E. and Gebhard, C. and Rehli, M. and Gonzalez, Vera J. and Eckstein, M. and Wiesmueller, M. and Erber, R. and Bruns, H. and Mackensen, A. and Voelkl, S. (2023) Oligoclonal expansion and loss of cytotoxic functionality of CAR-T cells in a DLBCL patient after CD19.CAR-T cell therapy. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

O

Ott, Claudia and Gerken, Michael and Hirsch, Daniela and Fest, Petra and Fichtner-Feigl, Stefan and Munker, Stefan and Schnoy, Elisabeth and Stroszczynski, Christian and Vogelhuber, Martin and Herr, Wolfgang and Evert, Matthias and Reng, Michael and Schlitt, Hans Juergen and Klinkhammer-Schalke, Monika and Teufel, Andreas (2018) Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. DIGESTION, 98 (3). pp. 143-152. ISSN 0012-2823, 1421-9867

P

Peeck, Micha and Pukrop, Tobias and Rohde, Veit and Beissbarth, Tim and Nietert, Manuel and Kirchner, Benjamin and Bleckmann, Annalen (2020) Impact on Long-Term Survival of Pre-OP Frailty of Patients with Limited Brain Metastases. In: 34. Deutscher Krebskongress (DKK), 19.-22. Februar 2020, Berlin.

Penack, O. and Dreger, P. and Ajib, S. and Ayuk, F. and Baermann, B.-N. and Bug, G. and Kriege, O. and Jentzsch, M. and Kobbe, G. and Koenecke, C. and Lutz, M. and Martin, S. and Schlegel, P. and Schroers, R. and von Tresckow, B. and Vucinic, V. and Subklewe, M. and Bethge, W. and Wolff, D. (2023) Management of Patients undergoing CAR T-Cell Therapy in Germany. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Penack, Olaf and Dreger, Peter and Ajib, Salem and Ayuk, Francis and Baermann, Ben-Niklas and Bug, Gesine and Kriege, Oliver and Jentzsch, Madlen and Kobbe, Guido and Koenecke, Christian and Lutz, Mathias and Martin, Sonja and Schlegel, Paul-Gerhard and Schroers, Roland and von Tresckow, Bastian and Vucinic, Vladan and Subklewe, Marion and Bethge, Wolfgang and Wolff, Daniel (2024) Management of Patients Undergoing CAR-T Cell Therapy in Germany. ONCOLOGY RESEARCH AND TREATMENT, 47 (3). ISSN 2296-5270, 2296-5262

Perl, M. and Haedenkamp, T. and Hiergeist, A. and Kunz, S. and Heinrich, P. and Brummer, C. and Vollmann, A. and Jachnik, B. and Herschberger, E. and Pyschkin, A. and Scheu, K. and Linker, R. and Gessner, A. and Hitzenbichler, F. and Hanses, F. and Knoedler, L. and Schmidleithner, L. and Salzberger, B. and Schmidt, B. and Burkhardt, R. and Herr, W. and Niedermair, T. and Brochhausen-Delius, C. and Haferkamp, S. and Inwald, E. C. and Seitz, S. and Kleigrewe, K. and Opitz, C. and Poeck, H. and Hau, P. (2023) The COVUR study - a prospective study to analyze the microbiome, metabolome and immune signatures in cancer patients suffering from COVID-19. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Perl, M. and Knoedler, L. and Shah, D. and Becker, L. and Herfeld, K. and Fooks-Koelbl, C.-H. and Krieger, M. and Lloshi, I and Fante, M. and Herr, W. and Schmidl, C. and Poeck, H. (2023) Modulation of CAR-T cell therapies by genome editing and microbial modulators of the immune system. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Perl, M. and Knödler, L. and Becker, L. M. and Shah, D. and Schmidl, C. and Poeck, H. (2022) Improvement of CAR-T cell effectiveness using polyclonal Genome modifications and modulators of the innate immune system. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Pfeifer, H. and Cayuela, J. -M. and Spiekermann, K. and Beck, J. and Jung, W. and Viardot, A. and Schaefer-Eckhart, K. and Reichle, A. and Maury, S. and Schmitz, N. and Heidenreich, D. and Panse, J. and Junghanss, C. and Raffoux, E. and Suarez, F. and Guillerm, G. and Alexis, M. and Lissandre, S. and Huguet, F. and Isnard, F. and Lepetre, S. and Escofffre-Barbe, M. and Ribera, J. -M. and Goekbuget, N. and Dombret, H. and Hoelzer, D. and Rousselot, P. and Ottmann, O. (2015) European working group for adult ALL phase II trial of nilotinib in combination with chemotherapy for first-line treatment in elderly patients with de novo Philadelphiachromosome positive acute lymphoblastic leukemia (EWALL-PH-02). KARGER, BASEL.

Pfirstinger, J. and Hierl, M. and Holler, E. and Mayer, S. and Wolff, D. and Andreesen, R. and Vogelhuber, M. (2011) Complementary and alternative medicine (CAM) in oncology patients - results from a single-center survey in outpatients with hematologic and solid malignancies. ONKOLOGIE, 34 (Suppl6). p. 41. ISSN 0378-584X

Pfirstinger, J. and Kattner, D. and Vogelhuber, M. (2010) When do oncology patients wish a consultation about advance directives? ONKOLOGIE, 33 (Suppl6). p. 181. ISSN 0378-584X

Pfirstinger, Jochen and Kattner, Daniel and Edinger, Matthias and Andreesen, Reinhard and Vogelhuber, Martin (2014) The Impact of a Tumor Diagnosis on Patients' Attitudes toward Advance Directives. ONCOLOGY, 87 (4). pp. 246-256. ISSN 0030-2414, 1423-0232

Platzbecker, U. and Lengfelder, E. and Goetze, K. and Roellig, C. and Kramer, M. and Sauer, M. and Albers, N. and Heuser, M. and Link, H. and Schaefer-Eckart, K. and Martin, S. and Krause, S. and Haenel, M. and Bochtler, T. and Jakob, A. and Reichle, A. and Biersack, H. and Baldus, C. and Goerner, M. and Basara, N. and Mezger, J. and Naumann, R. and Kuerschner, D. and de Wit, M. and Nolte, F. and Scholl, S. and Ringhoffer, M. and Tischler, H. J. and Greiner, J. and Kremers, S. and Machherndl-Spandl, S. and Koller, E. and Wattad, M. and Aschauer, G. and Radsak, M. and Kubin, T. and Salih, H. and Wolf, D. and Thiede, C. and Serve, H. and Duehrsen, U. and Hochhaus, A. and Bruemmendorf, T. and Bornhaeuser, M. and Doehner, H. and Ehninger, G. and Schlenk, R. F. (2016) Real life experience with ATRA-arsenic trioxide based regimen in acute promyelocytic leukemia - results of the prospective German intergroup Napoleon registry. KARGER, BASEL.

Pohl, S. and Heudobler, D. and Gebhard, C. and Hirabayashi, S. and Niemeyer, C. and Wlodarski, M. and Rehli, M. (2013) Genome-wide methylation profiling by MCIp-Seq reveals aberrant DNA methylation patterns in childhood MDS with GATA2-deficiency. KARGER, BASEL.

Pukrop, T. (2017) Entity-specific treatment of brain metastases. KARGER, BASEL.

Pukrop, T. (2016) Targeted-Therapy of brain metastasis of NSCLC, malignant melanoma and breast cancer. KARGER, BASEL.

Pukrop, T. (2017) Therapy of brain metastases. KARGER, BASEL.

Pukrop, T. and Lueke, F. and Wlochowitz, D. and Wolff, A. and Blazquez, R. (2017) PI3K-inhibition blocks CSF1 signaling in metastasis-associated macrophages and their metastasis-promoting function. KARGER, BASEL.

Pukrop, T. and Windschüttl, S. and Mueller, K. and Huppertz, G. and Herrmann-Johns, A. and Einhell, S. and Koller, M. (2022) First results of a comprehensive needs, quality of life and symptom creeening (NQS(2)) of cancer patients and resulting care in the daily routine of an interdisciplinary day hospital. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

R

Reichle, A. (2010) Bridging theory and therapeutic practice: From generalized disease models to particular patients. ONKOLOGIE, 33 (Suppl6). p. 71. ISSN 0378-584X

Reichle, A. (2013) Combined modularized tumor therapy - tumor biology - and prognostic factors: Bioengineering tumor response. KARGER, BASEL.

Reichle, A. (2012) Formal-pragmatic communication theory as prerequisite for an evolution-adjusted tumor pathophysiology. ONKOLOGIE, 35 (suppl6). p. 82. ISSN 0378-584X

Reichle, A. and Feyerabend, S. and Suedhoff, T. and Schulze, M. and Huebner, J. and Oberneder, R. and Baier, M. and Ruebel, A. and Bakhshandeh-Bath, A. (2010) A phase II study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and low-dose Treosulfane: anti-inflammatory and angiostatic treatment in patients with castration-refractory prostate cancer (CRPC). ONKOLOGIE, 33 (Suppl6). p. 61. ISSN 0378-584X

Reichle, A. and Gerner, C. and Haegeman, G. (2011) Criticizable claims for the validity of communication acts in biological systems: Therapeutic implications in cancer. ONKOLOGIE, 34 (Suppl6). p. 125. ISSN 0378-584X

Reichle, A. and Ghibelli, L. and Gerner, C. and Herr, W. and Haegeman, G. (2016) What does anakoinosis, communicative reprogramming of refractary tumors, accomplish? KARGER, BASEL.

Reichle, A. and Herr, W. (2014) Therapeutically coping genetic and molecular-genetic heterogeneity in metastatic tumors: Top-down strategies for targeting the tumors' normativity. KARGER, BASEL.

Reichle, A. and Hildebrandt, G. C. (2013) Applied systems biology for the control of metastatic cancer: Therapeutic top-down strategy for targeting the tumors' normativity. KARGER, BASEL.

Reichle, A. and Muqaku, B. and Eisinger, M. and Meier, S. M. and Tahir, A. and Pukrop, T. and Haferkamp, S. and Slany, A. and Gerner, C. (2017) Multi-omics analysis of serum samples demonstrates reprogramming of organ functions via systemic calcium mobilization and platelet activation in metastatic melanoma. KARGER, BASEL.

Reichle, A. and Vogelhuber, M. (2012) Biomodulatory therapy approaches: renal clear cell carcinoma. ONKOLOGIE, 35 (suppl6). p. 238. ISSN 0378-584X

Reichle, A. and Vogelhuber, M. and Andreesen, R. (2013) Long-term results of combined modularized, immune-modulatory, angiostatic, and antiinflammatory therapy in systemically pre-treated multi-systems Langerhans cell histiocytosis. KARGER, BASEL.

Reichle, A. and Vogelhuber, M. and Feyerabend, S. and Suedhoff, T. and Schulze, M. and Huebner, J. and Oberneder, R. and Baier, M. and Ruebel, A. and Birkholz, K. and Bakhshandeh-Bath, A. and Andreesen, R. (2011) A phase II study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and low-dose Treosulfan: Final results of a combined anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC). ONKOLOGIE, 34 (Suppl6). p. 10. ISSN 0378-584X

Reichle, A. and Vogelhuber, M. and Feyerabend, S. and Suedhoff, T. and Schulze, M. and Huebner, J. and Oberneder, R. and Ruebel, A. and Birkholz, K. and Bakhshandeh-Bath, A. and Andreesen, R. (2012) Combined anti-osteoplastic, anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC): Biologic features during therapy interruption and tumor progression. ONKOLOGIE, 35 (suppl6). p. 181. ISSN 0378-584X

Reichle, A. and Vogelhuber, M. and Hart, C. and Hafner, C. and Landthaler, M. and Berneburg, M. and Herr, W. (2014) Combined anti-Inflammatory and angiostatic treatment as first-or second-line therapy in patients with B-raf negative metastatic melanoma: A combined treatment of temsirolimus with pioglitazone, etoricoxib and low-dose trofosfamide (phase I trial). KARGER, BASEL.

Reichle, A. and Vogelhuber, M. and Kreuser, E. -D. and Wilke, J. and Wagner, H. and Straka, C. and Pronath, A. and Andreesen, R. (2011) A phase I study of lenalidomide with pioglitazone, dexamethasone and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory and angiostatic treatment as third-line therapy for patients (pts) suffering from multiple myeloma (MM). ONKOLOGIE, 34 (Suppl6). p. 160. ISSN 0378-584X

Reichle, A. and Walpinski, I and Vogelhuber, M. and Klebl, F. and Wiest, R. and Schulz, U. and Andreesen, R. (2013) Combined anti-inflammatory, immune-modulatory and angiostatic therapy in pre-treated patients with advanced hepatocellular carcinoma: Impact of treatment and disease related parameters on overall survival. KARGER, BASEL.

Reichle, A. and Walter, B. and Schrettenbrunner, I and Vogelhuber, M. and Grassinger, J. and Bross, K. and Wilke, J. and Suedhoff, T. and Wieland, W. and Rogenhofer, W. and Andreesen, R. (2010) C-reactive protein as a secretome-derived biomarker for predicting response to biomodulatory therapy in metastatic renal clear cell carcinoma. ONKOLOGIE, 33 (Suppl6). p. 131. ISSN 0378-584X

Reinwald, M. and Spiess, B. and Heinz, W. J. and Cornely, O. A. and Schwerdtfeger, R. and Hahn, J. and Krause, S. W. and Bertz, H. and Reuter, S. and Wolf, H. H. and Claus, B. and Boch, T. and Hofmann, W. -K and Buchheidt, D. (2014) Aspergillus specific PCR of specimens more adequately representing the infectious localization such as bronchoalveolar lavage, cerebrospinal fluid or tissue/effusion samples are superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis. KARGER, BASEL.

Renner, K. and Faerber, S. and Geiselhoeringer, A. -L. and Fante, M. and Schoenhammer, G. and Hacker, L. and Herr, W. and Andreesen, R. and Kreutz, M. (2014) Preserved effector functions of human CD4 and CD8 T cells under metabolic restriction. KARGER, BASEL.

Reuthner, K. and Aubele, P. and Menhart, K. and Harrer, D. and Herr, W. and Hahn, J. and Vogelhuber, M. and Reichle, A. and Heudobler, D. and Lueke, F. and Grube, M. (2023) Sustained complete remission with oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Riegel, C. and Boeld, T. and Huber, E. and Hoffmann, P. and Edinger, M. (2017) Effective treatment of severe acute gastrointestinal graft-versus-host disease by in vitro expanded donor regulatory T cells. KARGER, BASEL.

Roellig, C. and Serve, H. and Huettmann, A. and Noppeney, R. and Mueller-Tidow, C. and Krug, U. and Baldus, C. D. and Brandts, C. H. and Kunzmann, V and Einsele, H. and Kraemer, A. and Schaefer-Eckart, K. and Neubauer, A. and Burchert, A. and Giagounidis, A. and Krause, S. W. and Mackensen, A. and Aulitzky, W. and Herbst, R. and Haenel, M. and Kiani, A. and Frickhofen, N. and Kullmer, J. and Kaiser, U. and Link, H. and Geer, T. and Reichle, A. and Junghanss, C. and Bornhaeuser, M. and Schaich, M. and Thiede, C. and Schetelig, J. and Kramer, M. and Berdel, W. E. and Ehninger, G. (2018) The addition of sorafenib to standard AML treatment results in a substantial reduction in relapse risk and improved survival. Updated results from long-term follow-up of the randomized-controlled SORAML trial. KARGER, BASEL.

S

Sattler, C. and Hoffmann, P. and Weber, D. and Holler, B. and Fehn, U. and Plentz, A. and Beckhove, P. and Winkler, J. and Edinger, M. and Herr, W. and Holler, E. and Wolff, D. (2020) Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - a single center retrospective efficacy analysis. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Saussele, S. and Stein, M. and Gil, A. and Kossak-Roth, U. and Lauseker, M. and Hanfstein, B. and Proetel, U. and Schreiber, A. and Einsele, H. and Schafhausen, P. and Schubert, J. and Haenel, M. and Spiekermann, K. and Soekler, M. and Nerl, C. and Kremers, S. and Pfreundschuh, M. and Andreesen, R. and Hofmann, W-K and Hehlmann, R. and Hochhaus, A. and Hasford, J. and Gratwohl, A. and Mueller, M. C. and Pfirrmann, M. (2013) Health-related quality of life in patients with chronic myeloid leukemia: Results of a German cross-sectional study in patients previously registered in prospective, controlled clinical trials. KARGER, BASEL.

Schelker, R. and Mueller, G. and Hart, C. and Klatt, S. and Herr, W. and Grassinger, J. (2015) Effect of TGF-b1 and CXCL12 blocking on apoptosis, proliferation and cytarabine sensibility of acute myeloid leukemia (AML) cells cocultured/cotransplantated with multipotent mesenchymal stroma cells. KARGER, BASEL.

Schelker, R. C. and Barreiros, A. P. and Hart, C. and Herr, W. and Jung, E. -M. (2017) Qualitative and quantitative analysis of intrahepatic blood flow changes in patients with hereditary hemorrhagic telangiectasia (HHT). KARGER, BASEL.

Schelker, R. C. and Huber, E. and Herr, W. and Vogelhuber, M. (2015) Marked regression of myelofibrosis during reduced-dose dasatinib treatment in chronic myelogenous leukemia in accelerated phase. KARGER, BASEL.

Schelker, R. C. and Mueller, G. and Gottfried, E. and Seilbeck, A. and Hart, C. and Andreesen, R. and Grassinger, J. (2013) Bone marrow multipotent mesenchymal stroma cells support leukemic cell proliferation and reduce chemotherapy sensitivity in vitro. KARGER, BASEL.

Schemenau, J. and Strupp, C. and Wulfert, M. and Schroeder, T. and Nusch, A. and Langer, W. and Kalhori, N. and Haase, D. and Bruemmendorf, T. and Schuette, J. and Ganser, A. and Parmentier, S. and Schulte, K. and Plewe, D. and Losem, C. and Biekmann, E. and Hoffmann, W. and Hahn, L. and Neise, M. and Lollert, A. and Maintz, C. and Hinske, C. and Weissinger, F. and Heudobler, D. and Rodermann, E. and Culmann, H. and Kretschmar, T. and Steinmetz, T. and Severin, K. and Schmitz, S. and Haas, R. and Germing, U. and Hofmann, W-K and Gattermann, N. (2014) First report on the MDS Bioregistry project of the "Krebshilfe-Verbundforschungsprojekt MDS" of the German MDS study group. KARGER, BASEL.

Schreder, M. and Liebisch, P. and Hebart, H. and Holler, E. and Engelhardt, M. and Metzner, B. and Peest, D. and Aulitzky, W. and Straka, C. and Fischer, T. and Sezer, O. and Hentrich, M. and Ostermann, H. and Peschel, C. and Hess, G. and Hertenstein, B. and Wolf, H. -H and Jung, W. and Frickhofen, N. and Maschmeyer, G. and Langer, C. and Meisner, C. and Kanz, L. and Einsele, H. and Knop, S. (2016) Randomized comparison of pegylated IFN-a2b versus IFN-a2b maintenance following tandem autologous transplant in multiple myeloma. KARGER, BASEL.

Schubert, A. and Bleckmann, A. and Pukrop, T. and Binder, C. (2016) DVL3 in breast cancer and tumor progression. KARGER, BASEL.

Schubert, M.-L. and Blumenberg, V. and Zamir, E. and Schmidt, S. and Rohrbach, R. and Waldhoff, P. and Bozic, D. and von Bergwelt, M. and Mueller-Tidow, C. and Dreger, P. and Poeck, H. and Schmitt, M. and Subklewe, M. and Stein-Thoeringer, C. (2021) Associations of gut microbiome profiles with efficacy and toxicity in CD19-targeted chimeric antigen receptor (CAR) T cell treatment. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Schulz, C. and Laack, E. and Wolff, T. and Rueckert, A. and Reck, M. and Faehling, M. and Fischer, J. R. and de Wit, M. (2018) PACIFIC: a double-blind, placebo-controlled Phase III study of durvalumab as consolidation therapy after chemoradiation in patients with locally advanced, unresectable NSCLC. KARGER, BASEL.

Schwarzmeier, J. and Gerner, C. and Slany, A. and Mayer, R. and Gerner, M. and Reichle, A. (2018) Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia. KARGER, BASEL.

Siegloch, K. and Schmitz, N. and Friedrichs, B. and Hamilton, E. and Harrison, B. and van Imhoff, G. W. and Montoto, S. and Holler, E. and Ribera, J. M. and Delage, R. and Duehrsen, U. and Luan, J. -J. and Dreger, P. and Sureda, A. (2012) Hematopoietic stem cell transplantation in patients with Lymphomatoid Granulomatosis (LG): A survey of the lymphoma working party of the European Group for Blood and Marrow Transplantation (EBMT). ONKOLOGIE, 35 (suppl6). p. 247. ISSN 0378-584X

Singer, K. and Kastenberger, M. and Gottfried, E. and Hammerschmied, C. G. and Buettner, M. and Aigner, M. and Seliger, B. and Walter, B. and Schloesser, H. and Hartmann, A. and Andreesen, R. and Mackensen, A. and Kreutz, M. (2010) Warburg phenotype in renal cell carcinoma: High expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor. ONKOLOGIE, 33 (Suppl6). p. 128. ISSN 0378-584X

Sockel, K. and Frank, S. and Neu, A. and Ditschkowski, M. and Hilgendorf, I. and Goeckenjan, M. and Stoelzel, F. and Middeke, J. M. and Kroeger, N. and Ayuketang, Ayuk F. and Eder, M. and Bethge, W. and Finke, J. and Bertz, H. and Kobbe, G. and Kaufmann, M. and Platzbecker, U. and Beverungen, D. and Schmid, C. and von Bonin, M. and Heberling, L. and Teipel, R. and Bug, G. and Fraccaroli, A. and Tischer, J. and Holler, B. and Wolff, D. and Luft, T. and Roesler, W. and Schaefer-Eckart, K. and Dressler, S. and Scheid, C. and Holtick, U. and Klein, S. and Blau, I. -W. and Burchert, A. and Wulf, G. and Hasenkamp, J. and Kaun, S. and Wittke, C. and Wortmann, F. and Bornhaeuser, M. and Schetelig, J. (2020) Evaluation of pregnancies after allogeneic stem cell transplantation during the last 15years in Germany. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Spiess, B. and Reinwald, M. and Postina, P. and Cornely, O. A. and Heussel, C. -P and Heinz, W. and Lehrnbecher, T. and Bertz, H. and Hahn, J. and Janssen, G. and Claus, B. and Lauten, M. and Egerer, G. and Behrends, U. and Nathrath, M. and Wolf, H. -H and Gruhn, B. and Frickhofen, N. and Woessmann, W. and Will, S. and Merker, N. and Boch, T. and Hofmann, W. -K and Buchheidt, D. (2014) Detection of fungal DNA in Aspergillus PCR-negative tissue biopsy samples from immunocompromised hematological patients using DNA microarray technology improves diagnosis of invasive fungal infections (IFI). KARGER, BASEL.

Spoerl, S. and Erber, R. and Gerken, M. and Fischer, R. and Taxis, J. and Meier, J. K. and Geppert, C. and Hartmann, A. and Beckhove, P. and Mackensen, A. and Reichert, T. and Spanier, G. and Spoerl, S. (2021) A20 as a novel prognostic factor for recurrence and patients' survival in oral squamous cell carcinoma. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Sporrer, D. and Koestler, J. and Gessner, A. and Oefner, P. and Holler, E. (2013) The Influence of Rifaximin prophylaxis on intestinal microbiota, GvHD and infections in ASCT. KARGER, BASEL.

Sterz, U. and Grube, M. and Herr, W. and Menhart, K. and Vogelhuber, M. (2020) Dual checkpoint inhibition in advanced metastatic osteosarcoma leads to remission of all tumor manifestations a case report of a stunning success in a 37 year-old patient. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Stritzke, F. and Dahl, S. and Dassler-Plenker, J. and Joachim, L. and Buschmann, D. and Giebel, B. and Bassermann, F. and Coch, C. and Hartmann, G. and Heidegger, S. and Poeck, Hendrik (2022) Reprogramming the Biogenesis and immunomodulatory Function of extracellular Tumor Vesicles through Activation of the RIG-I Pathway. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Stritzke, F. and Joachim, L. and Bek, S. and Nedelko, T. and Bassermann, F. and Heidegger, S. and Poeck, H. (2020) Tumor-intrinsic RIG-I signaling modulates immunogenicity of tumor cell-derived extracellular vesicles that can mediate T cell-based antitumor immunity. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Strobl, C. and Henrich, F. and Peter, K. and Singer, K. and Kreutz, M. and Kremer, A. and Mackensen, A. and Aigner, M. (2016) MTA (5 '-deoxy-5 '-methylthioadenosine) suppresses function of human mDC and T cells and represents a mechanism of tumor immune escape. KARGER, BASEL.

Strobl, C. and Henrich, F. and Singer, K. and Gronwald, W. and Bosserhoff, A. and Kreutz, M. and Poller, K. and Kremer, A. and Mackensen, A. and Aigner, M. (2015) 5 '-deoxy-5 '-methylthioadenosine suppresses human T cell function and represents a novel mechanism of tumor immune escape. KARGER, BASEL.

Strobl, C. D. and Henrich, F. C. and Singer, K. and Peter, K. and Kreutz, M. and Kremer, A. and Boettcher, M. and Mougiakakos, D. and Mackensen, A. and Aigner, M. (2017) Inhibition of human T cells by the tumor metabolite MTA: mechanism of action and MTAP-overexpression in T cells as putative strategy to improve antitumor activity. KARGER, BASEL.

T

Teschner, D. and Kahlert, L. and Frey, M. and Khan, S. A. and Wagner, E. M. and Theobald, M. and Herr, W. and Hartwig, U. F. (2016) Improved recovery of CD45RAnegCD8pos T lymphocytes and Induction of CD8-mediated antiviral reactivity following positive selection versus depletion of CD45RApos cells using CD45RA MicroBeads. KARGER, BASEL.

Teufel, A. and Evert, K. and Itzel, T. and Evert, M. and Koch, C. and Vogelhuber, M. and Schulte, N. and Demir, H. and Herr, W. and Gaiser, T. and Waidmann, O. and Ebert, M. (2020) Differential Gene Expression May Predict Response to Somatostatin Analogues (SSAs) in Gastrointestinal (GI) Neuroendocrine Tumors (NETs). In: 17th Annual European-Neuroendocrine-Tumor-Society (ENETS) Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, MAR 11-13, 2020, Virtual Conference.

Teufel, A. and Evert, K. and Itzel, T. and Koch, C. and Vogelhuber, M. and Schulte, N. and Mueller-Schilling, M. and Gaiser, T. and Waidmann, O. and Ebert, M. and Evert, M. and Herr, W. (2019) Evaluation of Gene Expression Changes Associated with Response to Somatostatin Analogues (SSAs) in Gastrointestinal (GI) Neuroendocrine Tumors (NETs). KARGER, BASEL.

Thiel, A. and Singer, K. and Renner-Sattler, K. and Kreutz, M. (2016) Targeting cancer metabolism for the improvement of checkpoint therapy. KARGER, BASEL.

Thiele Orberg, E. and Goettert, S. and Hiergeist, A. and Herhaus, P. and Verbeek, M. and Gessner, A. and Herr, W. and Bassermann, F. and Holler, E. and Poeck, H. (2021) Microbial-derived metabolites induce epithelial recovery via the STING pathway in mice and men and protect from graft-versus-host disease. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Thiele Orberg, E. and Goettert, S. and Pianka, A. and Heidegger, S. and Poeck, H. (2020) Type-I interferon-inducing microbial-derived metabolites promote resistance to gastrointestinal damage after chemotherapy and irradiation and protect from graft-versus-host disease. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Thiele Orberg, E. and Meedt, E. and Hiergeist, A. and Xue, J. and Heinrich, P. and Goettert, S. and Ghimire, S. and Goeldel, S. and Schwarz, A. and Herhaus, P. and Verbeek, M. and Weber, D. and Edinger, M. and Wolff, D. and Kleigrewe, K. and Herr, W. and Bassermann, F. and Gessner, A. and Deng, L. and Holler, E. and Poeck, H. (2023) Bacterial and bacteriophage consortia are associated with protective intestinal immuno-modulatory metabolites in allogeneic stem cell transplantation patients. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Thomas, S. and Lemmermann, N. and Klobuch, S. and Podlech, J. and Plachter, B. and Theobald, M. and Reddehase, M. and Herr, W. (2015) Evaluating human T-cell therapies of systemic cytomegalovirus organ disease in HLA-transgenic mice. KARGER, BASEL.

Thomas, Simone (2022) Bispecific Antibodies. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Thurner, L. and Poeschel, V. and Haioun, C. and Houot, R. and Gaulard, P. and Molina, T. and Rosenwald, A. and Andre, M. and Hoffmann, J. and Dreyling, M. and Casasnovas, O. and Maisonneuve, H. and Tilly, H. and Illmer, T. and Mayer, S. and Kirchen, H. and La Rosee, P. and Loeffler, M. and Ziepert, M. and Altmann, B. and Held, G. (2020) Analysis of a safety run-in cohort from NIVEAU, a phase 3 study for patients with aggressive Non-Hodgkin lymphoma in first relapse or progression not eligible for High-Dose Chemotherapy (HDT) testing Nivolumab in combination with (R)-GemOx. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Topp, M. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H-A and Reichle, A. and Marks, R. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M-E and Einsele, H. and Hoelzer, D. and Bargou, R. (2012) Anti-CD19 BiTE blinatumomab induces high complete remission rate and prolongs overall survival in adult patients with relapsed/refractory B-precursor ALL. ONKOLOGIE, 35 (suppl6). p. 186. ISSN 0378-584X

Topp, M. S. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. -A and Reichle, A. and Marks, R. and Klappers, P. and Mergen, N. and Nagorsen, D. and Kufer, P. and Goebeler, M. -E and Einsele, H. and Hoelzer, D. and Bargou, R. (2011) Clinical activity of the anti-CD19 bite (R) blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL): Interim results of a phase II study. ONKOLOGIE, 34 (Suppl6). p. 16. ISSN 0378-584X

Tschanter, P. and Krug, U. and Fueller, M. and Klein, M. and Goellner, S. and Rohde, C. and Roellig, C. and Thiede, C. and Lilly, M. A. and Haack, B. and Koschmieder, A. and Stelljes, M. and Dugas, M. and Koschmieder, S. and Gerss, J. and Butterfass-Bahloul, T. and Wagner, R. and Eveslage, M. and Thiem, U. and Krause, S. W. and Kaiser, U. and Kunzmann, V and Steffen, B. and Noppeney, R. and Herr, W. and Baldus, C. D. and Schmitz, N. and Goetze, K. and Reichle, A. and Kaufmann, M. and Neubauer, A. and Schaefer-Eckart, K. and Haenel, M. and Peceny, R. and Frickhofen, N. and Kiehl, M. and Giagounidis, A. and Goerner, M. and Repp, R. and Link, H. and Kiani, A. and Naumann, R. and Bruemmendorf, T. H. and Serve, H. and Ehninger, G. and Berdel, W. E. and Mueller-Tidow, C. (2015) DNMT3A mutations in exon 23 are associated with improved survival in AML patients treated with Azacytidine plus standard chemotherapy. KARGER, BASEL.

U

Ugocsai, P. and Klobuch, S. and Zaiss, S. and Dietz, D. and Wolff, D. and Holler, E. and Herr, W. and Reichle, A. (2014) Targeting the tumors' systems biology: Combined biomodulatory therapy in refractory Hodgkin's lymphoma. KARGER, BASEL.

Ugocsai, Peter and Gerthofer, Valeria and Weber, Florian and Rechenmacher, Michael and Hatzipanagiotou, Maria and Ortmann, Olaf and Seitz, Stephan (2020) Intrapericardial Chemotherapy for The Management of Malignant Pericardial Effusion of a Metastatic Breast Cancer Patient-A Case Report. In: 34. Deutscher Krebskongress (DKK), 19.-22. Februar 2020, Berlin.

Ullrich, E. and Bakthiar, S. and Salzmann-Manrique, E. and Bremm, M. and Gerstner, S. and Mackensen, A. and Bader, P. and Hoffmann, P. and Holler, E. and Edinger, M. and Wolff, D. (2015) Bidirectional relation between acute GVHD and NK cell subset reconstitution following allogeneic stem cell transplantation. KARGER, BASEL.

Ullrich, E. and Meinhardt, K. and Bauer, R. and Kroeger, I and Schneider, J. and Ganss, F. and Dudziak, D. and Rehli, M. and Mackensen, A. (2012) The role of tissue specific homing of different NK cell subpopulations for the prevention of GVHD in a murine model for HSCT. ONKOLOGIE, 35 (suppl6). pp. 91-92. ISSN 0378-584X

V

Vatter, S. and Klobuch, S. and Herr, W. and Thomas, S. (2014) Gene transfer of HLA-DP specific T-cell receptors as a novel approach in adoptive immunotherapy of leukemias. KARGER, BASEL.

Vatter, S. and Zwerger, M. and Mirbeth, C. and Sieboerger, M. and Herr, W. and Thomas, S. (2016) HLA-DPB1 specific T-cell receptors as novel approach in adoptive immunotherapy of leukemias. KARGER, BASEL.

Vatter, S. and Zwerger, M. and Schmid, M. and Mirbeth, C. and Herr, W. and Thomas, S. (2017) HLA-DPB1 specific T-cell receptors are potent mediators of anti-leukemia reactivity in vitro as well as in a xenograft mouse model. KARGER, BASEL.

Vogelhuber, M. and Andreesen, R. and Meidenbauer, N. and Reichle, A. (2011) Compassionate use of Lenalidomide with Pioglitazone, Etoricoxib, Dexamethasone and low-dose Treosulfan: Combined anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with docetaxel-refractory, castration-resistant prostate cancer (CRPC). ONKOLOGIE, 34 (Suppl6). p. 180. ISSN 0378-584X

W

Weber, Daniela (2022) Nutrition and microbiomes in the context of cellular therapies. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Wehler, D. and Bittrich, M. and Kriegsmann, K. and Tietze-Buerger, C. and Grube, M. and Vucinic, V. and Burchert, A. and Kunz, C. and Schmidt-Hieber, M. and Rank, A. and Kroeger, N. (2021) Mobilization and collection of hematopoietic stem cells in poorly mobilizable patients with multiple myeloma and lymphoma across Germany: Interim analysis of the OPTIMOB study. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Wertheimer, T. and Zwicky, P. and Rindlisbacher, L. and Vermeer, M. and Sparano, C. and Ruckert, T. and Ingelfinger, F. and Muschaweckh, A. and Koehler, N. and Zeiser, R. and Oukka, M. and Korn, T. and Tugues, S. and Becher, B. (2023) IL-23 stabilizes an effector Treg program in the tumor microenvironment. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Winkler, J. and Habenicht, K. and Bootz, A. and Schaefer, S. and Vasova, I. and Fante, M. and Schneider, A. and Rehli, M. and Hoffmann, P. and Roesler, W. and Edinger, M. and Herr, W. and Mackensen, A. and Winkler, T. H. and Wolff, D. (2023) Expansion of CD19+CD38high Plasmablasts at day 90 after allogeneic stem cell transplantation predicts chronic GVHD. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Wolff, D. and Greinix, H. and Lawitschka, A. and Halter, J. and Schwerdtfeger, R. and Meier, J. and Hildebrandt, G. and Dietrich, T. and Rieger, K. and Marks, C. and Kleiter, I and Bertz, H. and Holler, E. (2010) German-Austrian-Swiss consensus on clinical practice in chronic GVHD: guidance for diagnosis, immunosuppressive treatment and supportive care of chronic graft-versus-host disease. ONKOLOGIE, 33 (Suppl6). p. 30. ISSN 0378-584X

Wolff, D. and Hilgendorf, I. and Wagner-Drouet, E. -M. and Jedlickova, Z. and Middeke, J. M. and Ayuk, F. A. and Zeiser, R. and Lawitschka, A. and Halter, J. and Klein, S. A. and Holler, E. and Greinix, H. (2018) Changes in immunosuppressive treatment of chronic graft-versus-host disease - comparison of 2 surveys within hematopoietic stem cell transplant centers in Germany, Austria and Switzerland performed in 2009 and 2018. KARGER, BASEL.